Business Description
Finch Therapeutics Group Inc
NAICS : 325412
SIC : 2834
ISIN : US31773D2009
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.83 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 1.32 | |||||
Debt-to-EBITDA | -0.88 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -13.07 | |||||
Beneish M-Score | -5.35 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -76.3 | |||||
3-Year EBITDA Growth Rate | 7.1 | |||||
3-Year EPS without NRI Growth Rate | 13 | |||||
3-Year FCF Growth Rate | 4 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 46.29 | |||||
9-Day RSI | 47.3 | |||||
14-Day RSI | 47.4 | |||||
6-1 Month Momentum % | -39.55 | |||||
12-1 Month Momentum % | -77.13 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.33 | |||||
Quick Ratio | 6.33 | |||||
Cash Ratio | 6.15 | |||||
Days Sales Outstanding | 428.11 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.6 | |||||
Shareholder Yield % | 234.14 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -33265.42 | |||||
Net Margin % | -71351.4 | |||||
FCF Margin % | -29457.01 | |||||
ROE % | -185.98 | |||||
ROA % | -90.09 | |||||
ROIC % | -74.11 | |||||
ROC (Joel Greenblatt) % | -108.38 | |||||
ROCE % | -47.17 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 46.64 | |||||
PB Ratio | 0.17 | |||||
Price-to-Tangible-Book | 0.17 | |||||
EV-to-EBIT | -0.25 | |||||
EV-to-Forward-EBIT | -0.13 | |||||
EV-to-EBITDA | -0.26 | |||||
EV-to-Forward-EBITDA | -0.16 | |||||
EV-to-Revenue | 84.26 | |||||
EV-to-Forward-Revenue | 73.6 | |||||
EV-to-FCF | -0.29 | |||||
Earnings Yield (Greenblatt) % | -400 | |||||
FCF Yield % | -832.29 |